High-grade B-cell lymphoma, not otherwise specified: a multi-institutional retrospective study

In this multi-institutional retrospective study, we examined the characteristics and outcomes of 160 patients with high-grade B-cell lymphoma, not otherwise specified (HGBL-NOS)—a rare category defined by high-grade morphologic features and lack of MYC rearrangements with BCL2 and/or BCL6 rearrangem...

Descripción completa

Detalles Bibliográficos
Autores principales: Zayac, Adam S., Landsburg, Daniel J., Hughes, Mitchell E., Bock, Allison M., Nowakowski, Grzegorz S., Ayers, Emily C., Girton, Mark, Hu, Marie, Beckman, Amy K., Li, Shaoying, Medeiros, L. Jeffrey, Chang, Julie E., Stepanovic, Adam, Kurt, Habibe, Sandoval-Sus, Jose, Ansari-Lari, M. Ali, Kothari, Shalin K., Kress, Anna, Xu, Mina L., Torka, Pallawi, Sundaram, Suchitra, Smith, Stephen D., Naresh, Kikkeri N., Karimi, Yasmin H., Epperla, Narendranath, Bond, David A., Farooq, Umar, Saad, Mahak, Evens, Andrew M., Pandya, Karan, Naik, Seema G., Kamdar, Manali, Haverkos, Bradley, Karmali, Reem, Oh, Timothy S., Vose, Julie M., Nutsch, Heather, Rubinstein, Paul G., Chaudhry, Amina, Olszewski, Adam J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The American Society of Hematology 2023
Materias:
Clinical Trials and Observations
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10598493/
https://www.ncbi.nlm.nih.gov/pubmed/37171397
http://dx.doi.org/10.1182/bloodadvances.2023009731

Ejemplares similares

Ejemplares similares